These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16954574)

  • 21. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
    Aoki J; Kirtane AJ; Dangas GD; Lansky AJ; Morales A; Kimura M; Kim YH; Moussa I; Weisz G; Kreps EM; Collins M; Frankin-Bond T; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2008 Jan; 101(1):58-62. PubMed ID: 18157966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
    Quizhpe AR; Feres F; de Ribamar Costa J; Abizaid A; Maldonado G; Costa R; Abizaid A; Cano M; Moreira AC; Staico R; Mattos LA; Tanajura LF; Chaves A; Centemero M; Sousa AM; Sousa JE
    Am Heart J; 2007 Aug; 154(2):373-8. PubMed ID: 17643591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction.
    Kornowski R; Vaknin-Assa H; Lev E; Ben-Dor I; Teplitsky I; Rechavia E; Brosh D; Fuchs S; Assali A
    Acute Card Care; 2008; 10(3):167-72. PubMed ID: 18803074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.
    Williams DO; Abbott JD; Kip KE;
    Circulation; 2006 Nov; 114(20):2154-62. PubMed ID: 17060386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions.
    Jeger RV; Schneiter S; Kaiser C; Bonetti PO; Brunner-La Rocca H; Handke M; Osswald S; Buser PT; Pfisterer ME;
    Cardiology; 2009; 112(1):49-55. PubMed ID: 18580059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcomes following coronary stenting.
    Anstrom KJ; Kong DF; Shaw LK; Califf RM; Kramer JM; Peterson ED; Rao SV; Matchar DB; Mark DB; Harrington RA; Eisenstein EL
    Arch Intern Med; 2008 Aug; 168(15):1647-55. PubMed ID: 18695078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting compared with bare-metal coronary stents among elderly patients.
    Groeneveld PW; Matta MA; Greenhut AP; Yang F
    J Am Coll Cardiol; 2008 May; 51(21):2017-24. PubMed ID: 18498954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].
    Lozano I; García-Camarero T; Carrillo P; Baz JA; de la Torre JM; López-Palop R; Pinar E; Salvatella N; Avanzas P; Valdés M
    Rev Esp Cardiol; 2009 Jan; 62(1):39-47. PubMed ID: 19150013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results.
    Khattab AA; Otto A; Hochadel M; Toelg R; Geist V; Richardt G
    J Interv Cardiol; 2007 Apr; 20(2):100-6. PubMed ID: 17391217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
    J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.
    Ruiz-Nodar JM; Marín F; Sánchez-Payá J; Hurtado JA; Valencia-Martín J; Manzano-Fernández S; Roldán V; Pérez-Andreu V; Sogorb F; Valdés M; Lip GY
    Eur Heart J; 2009 Apr; 30(8):932-9. PubMed ID: 19246502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
    Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
    Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).
    Sheiban I; Sillano D; Biondi-Zoccai G; Chieffo A; Colombo A; Vecchio S; Margheri M; Gunn JP; Raina T; Liistro F; Bolognese L; Lee MS; Tobis J; Moretti C
    J Am Coll Cardiol; 2009 Sep; 54(13):1131-6. PubMed ID: 19761932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-eluting stent use after coronary atherectomy: results from a multicentre experience - The ROTALINK I study.
    Cortese B; Aranzulla TC; Godino C; Chizzola G; Zavalloni D; Tavasci E; De Benedictis M; Ettori F; Presbitero P; Colombo A
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):665-72. PubMed ID: 25575276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
    Pasceri V; Patti G; Speciale G; Pristipino C; Richichi G; Di Sciascio G
    Am Heart J; 2007 May; 153(5):749-54. PubMed ID: 17452148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.
    Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Li JJ; Qin XW; Liu HB; Wu YJ; Chen J; Yao M; You SJ; Yuan JQ; Dai J; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):612-6. PubMed ID: 19323921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.